Diabetes, Vol 45, Issue 6 736-741, Copyright © 1996 by American Diabetes Association

ARTICLES

Are insulin and proinsulin independent risk markers for premature coronary artery disease ?

RJ Katz, RE Ratner, RM Cohen, E Eisenhower and D Verme
Department of Medicine, Division of Cardiology, George Washington University School of Medicine, Washington, DC 20037, USA.

Controversy persists about whether hyperinsulinemia and hyperproinsulinemia are independent risk markers for coronary atherosclerosis. A common limitation of most previous studies has been imprecise categorization of disease status in normal and coronary artery disease (CAD) groups. We assessed the relationship of pancreatic beta-cell secretory products and premature CAD in a case-control study of 134 nondiabetic subjects, aged < or = 55 years old, carefully defined for CAD status by catheterization and/or thallium stress studies. Case patients comprised 66 patients with premature CAD, and control subjects (non-CAD group) included 68 patients without CAD but with traditional CAD risk factors and chest pain and/or abnormal electrocardiograms but normal catheterization and/or thallium stress studies. In addition to the CAD and non-CAD group comparison, both groups were compared with a reference group of 27 mixed lean and obese control volunteers. All CAD and non-CAD patients had a 3-h 75-g oral glucose tolerance test with measurement of fasting and post-glucose load immunoreactive insulin (IRI), specific insulin (INS), proinsulin-like material (PI), and C-peptide. Increased fasting insulin and fasting proinsulin levels both were statistically significantly associated with higher odds of being in either the premature CAD and the non-CAD groups when compared with the reference group in a polychotomous logistic regression model (odds ratio of at least 1.20 for a 20% increase in each beta-cell secretory product in both comparisons, P < 0.05). However, increased pancreatic beta-cell secretory hormone levels did not show a statistically significant relative risk for being in the premature CAD group when compared with the non-CAD group. After adjustment for BMI, all statistically significant associations disappeared for IRI, INS, and PI when the odds favoring being in the CAD and non-CAD groups were compared versus the reference group. Furthermore, the odds of being in the premature CAD and non-CAD groups when compared with the reference group were not significantly associated to the ratio of PI to insulin and C-peptide. Thus, although there is a statistically significant association between the odds of having premature CAD with elevated insulin and proinsulin levels compared with the reference group, these findings are equally common in subjects with traditional CAD risk factors without detectable CAD. Furthermore, the association of higher insulin and proinsulin levels with the likelihood of a patient having or not having CAD disappears after adjustment for BMI, suggesting that insulin and proinsulin are not independent risk markers but are primarily dependent on obesity.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. M. Adams, A. E. Taylor, W. F. Crowley Jr., and J. E. Hall Polycystic Ovarian Morphology with Regular Ovulatory Cycles: Insights into the Pathophysiology of Polycystic Ovarian Syndrome J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4343 - 4350. [Abstract] [Full Text] [PDF]

				A. Pfutzner, T. Kunt, C. Hohberg, A. Mondok, S. Pahler, T. Konrad, G. Lubben, and T. Forst Fasting Intact Proinsulin Is a Highly Specific Predictor of Insulin Resistance in Type 2 Diabetes Diabetes Care, March 1, 2004; 27(3): 682 - 687. [Abstract] [Full Text] [PDF]

				A. J.G. Hanley, G. McKeown-Eyssen, S. B. Harris, R. A. Hegele, T. M.S. Wolever, J. Kwan, P. W. Connelly, and B. Zinman Cross-Sectional and Prospective Associations Between Proinsulin and Cardiovascular Disease Risk Factors in a Population Experiencing Rapid Cultural Transition Diabetes Care, July 1, 2001; 24(7): 1240 - 1247. [Abstract] [Full Text] [PDF]

				L. Bokemark, J. Wikstrand, and B. Fagerberg Intact Insulin, Insulin Propeptides, and Intima-media Thickness in the Femoral Artery in 58-year-old Clinically Healthy Men: The Atherosclerosis and Insulin Resistance Study Angiology, April 1, 2001; 52(4): 237 - 245. [Abstract] [PDF]

				M. Cranmer, S. Louie, R. H. Kennedy, P. A. Kern, and V. A. Fonseca Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Is Associated with Hyperinsulinemia and Insulin Resistance Toxicol. Sci., August 1, 2000; 56(2): 431 - 436. [Abstract] [Full Text] [PDF]

				H.-M. Lakka, T. A. Lakka, J. Tuomilehto, J. Sivenius, and J. T. Salonen Hyperinsulinemia and the Risk of Cardiovascular Death and Acute Coronary and Cerebrovascular Events in Men: The Kuopio Ischaemic Heart Disease Risk Factor Study Arch Intern Med, April 24, 2000; 160(8): 1160 - 1168. [Abstract] [Full Text] [PDF]

				O. Pinhas-Hamiel, D. Standiford, D. Hamiel, L. M. Dolan, R. Cohen, and P. S. Zeitler The Type 2 Family: A Setting for Development and Treatment of Adolescent Type 2 Diabetes Mellitus Arch Pediatr Adolesc Med, October 1, 1999; 153(10): 1063 - 1067. [Abstract] [Full Text] [PDF]

				S. M. Haffner The Importance of Hyperglycemia in the Nonfasting State to the Development of Cardiovascular Disease Endocr. Rev., October 1, 1998; 19(5): 583 - 592. [Abstract] [Full Text]

				S. M. Haffner, R. D'Agostino Jr, L. Mykkanen, C. N. Hales, P. J. Savage, R. N. Bergman, D. O'Leary, M. Rewers, J. Selby, R. Tracy, et al. Proinsulin and Insulin Concentrations in Relation to Carotid Wall Thickness : Insulin Resistance Atherosclerosis Study Stroke, August 1, 1998; 29(8): 1498 - 1503. [Abstract] [Full Text] [PDF]

				B. Zethelius, L. Byberg, C. N. Hales, H. Lithell, and C. Berne Proinsulin Is an Independent Predictor of Coronary Heart Disease: Report From a 27-Year Follow-Up Study Circulation, May 7, 2002; 105(18): 2153 - 2158. [Abstract] [Full Text] [PDF]